H.C. Wainwright reiterates Oklo stock rating at buy, $90 target By Investing.com

Oklo reported a first-quarter fiscal 2026 net loss of $33.1 million, or $0.19 per share, with no revenue as the company remains in development stage. Operating expenses fell 10% sequentially to $51.5 million from $57.1 million, but the company remains pre-revenue and is still expected to be unprofitable this year. H.C. Wainwright reiterated a Buy rating and $90 price target, but the stock was indicated as overvalued and traded lower in aftermarket activity.

Analysis

The market is still treating Oklo as a story stock, but the first-order issue is not the quarterly loss — it is the widening gap between valuation and tangible de-risking milestones. In pre-revenue infrastructure names, the stock is effectively a long-duration option on regulatory execution, but once the market stops paying for the narrative, multiple compression can be abrupt because there is no near-term earnings anchor. That makes the equity far more sensitive to any delay in permitting, project financing, or offtake conversion than to another modest quarter of burn reduction.

The bigger second-order read-through is to the broader nuclear complex: names with clearer commercialization pathways should start to outpace pure developers if capital gets more discriminating. Any weakness in OKLO can actually be a positive relative signal for utilities, fuel-cycle, and equipment vendors with existing cash flows, since investors will rotate toward businesses where timelines are shorter and dilution risk is lower. If the thematic trade cools, the market is likely to punish the highest-duration exposure first, then re-rate the ecosystem based on path-to-cash instead of technology optionality.

Near term, the stock is vulnerable over the next 1-3 months because there is no obvious catalyst that converts promises into revenue, while elevated expectations leave little room for execution slippage. The main bullish reversal would be a concrete commercial milestone — binding customer commitments, regulatory progress, or financing clarity — that turns the equity from a concept into a project-development story. Absent that, any broad risk-off move in long-duration growth should compress the multiple faster than fundamentals deteriorate.

The contrarian angle is that the market may be underestimating how quickly sentiment can reprice if investors decide the current valuation is effectively financing future dilution rather than future earnings. That said, a full short is dangerous because narrative momentum can persist for months even when fundamentals lag. The better expression is to stay short the exuberance in the highest-beta version of the trade while owning lower-duration beneficiaries of the same theme.

Key Decisions for Investors

• Short OKLO on any post-earnings strength for a 1-3 month horizon; risk/reward favors a fade because valuation is ahead of commercialization and there is no near-term revenue catalyst to reset expectations.
• Pair trade: short OKLO / long a lower-duration nuclear beneficiary such as NNE or a regulated utility exposure with nuclear optionality for 2-6 months; this captures the theme while reducing multiple-compression risk.
• Use call spreads rather than outright longs if expressing a bullish view on OKLO; the only attractive upside path is a discrete de-risking event, so cap premium paid and avoid unlimited theta bleed over the next quarter.
• If OKLO drops 15-20% on no-new-information selloff, cover part of the short; the stock can remain momentum-driven, and the best risk/reward often comes from trading around sentiment extremes rather than holding a full-sized core short.
• Set a catalyst watchlist for regulatory or offtake announcements over the next 1-2 quarters; only add long exposure after a concrete milestone, not on headline analyst reiterations.